Indication
Tricuspid Atresia
1 clinical trial
1 product
Clinical trial
Prospective, Open-labeled, Single-arm Clinical Trial to Evaluate the Safety and Efficacy of the Second-generation Tissue Engineered Vascular Graft as Vascular Conduits for Extracardiac Total Cavopulmonary Connection.Status: Recruiting, Estimated PCD: 2025-08-01